Common use of Safe Harbor Statement Clause in Contracts

Safe Harbor Statement. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xx

Appears in 2 contracts

Samples: d1io3yog0oux5.cloudfront.net, content.equisolve.net

AutoNDA by SimpleDocs

Safe Harbor Statement. This press release announcement contains forward-looking statements. These statements within are made under the meaning of Section 27A “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1933, 1995. These forward-looking statements can be identified by terminology such as amended, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, similar statements. Statements that are intended to be covered by the "safe harbor" created by those sections. Forwardnot historical facts, including statements about XPeng’s beliefs and expectations, are forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which uncertainties. A number of factors could cause actual results to differ materially from those contained in the any forward-looking statementsstatement, as a result including but not limited to the following: XPeng’s goal and strategies; XPeng’s expansion plans; XPeng’s future business development, financial condition and results of various factors including those operations; the trends in, and size of, China’s EV market; XPeng’s expectations regarding demand for, and market acceptance of, its products and services; XPeng’s expectations regarding its relationships with customers, contract manufacturers, suppliers, third-party service providers, strategic partners and other stakeholders; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks and uncertainties described is included in XPeng’s filings with the Risk Factors and SEC. All information provided in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only this press release is as of the date made. Except as otherwise required by the federal securities lawsof this press release, we disclaim and XPeng does not undertake any obligation or undertaking to publicly release any updates or revisions to update any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in eventsstatement, conditions or circumstances except as required under applicable law. View source version on which any such statement is based. CONTACTxxxxxxxxxxxx.xxx: MZ North America Xxxx Xxxxxx Chairman Directxxxxx://xxx.xxxxxxxxxxxx.xxx/news/home/20210408005568/en/ For Investor Enquiries: IR Department XPeng Inc. Email: xx@xxxxxxxx.xxx Xxxxx Xxx The Xxxxxxxx Group Tel: +0-000-000-0000 or +00-00-0000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Webxxxxx@xxx-xx.xxx For Media Enquiries: xxx.xxxxxxx.xxXxxxx Xxxxxx XPeng Inc. Tel: +000-0000-0000 or +00-0000-0000-000

Appears in 2 contracts

Samples: ir.xiaopeng.com, ir.xiaopeng.com

Safe Harbor Statement. This press release contains includes forward-looking statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19331995. For this purpose, as amendedany statements contained herein, other than statements of historical fact, including our strategy and Section 21E our future operations and opportunities, including our plans regarding the manner and timing for the launch and sale of the Securities Exchange and Exchange Act of 1934PERTZYE, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forwardconstitute forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based Actual results may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the indicated by such forward-looking statements, statements as a result of various important factors, including our ability to satisfy FDA and other regulatory requirements, our ability to develop and maintain the necessary sales, marketing, supply chain and distribution capabilities to successfully commercialize PERTZYE, and the other factors including those risks and uncertainties described in Item 1A (Risk Factors) of our Annual Report on Form 10-K Corrected and Restated filed with the Risk Factors Securities and Exchange Commission (the SEC) on March 14, 2013 and in Management's Discussion our subsequent filings with the SEC. In addition, the statements in this press release reflect our expectations and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak beliefs only as of the date madeof this release. Except as otherwise required by We anticipate that subsequent events and developments will cause our expectations and beliefs to change. However, while we may elect to update these forward-looking statements publicly at some point in the federal securities lawsfuture, we specifically disclaim any obligation to do so, whether as a result of new information, future events or undertaking to publicly release any updates or revisions to any otherwise, except as may be required by law. Our forward-looking statement contained herein (statements do not reflect the potential impact of any acquisitions, mergers, dispositions, business development transactions, joint ventures or elsewhere) to reflect investments that we may make or enter into. These forward-looking statements should not be relied upon as representing our views as of any change in our expectations with regard thereto or any change in eventsdate after the date of this release. Contacts CRTX Investor Relations Contact: Xxxx Xxxxxxxx, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: Vice President, Strategy and Business Development, +0-000-000-0000 Email0000, xxxx.xxxxxxxx@xxxx.xxx CRTX Media Relations Contact: xxxx.xxxxxx@xxxxxxx.xx WebXxxxxxxxx-Xxxxxxx, Xxxxxx Xxxxx, +0-000-000-0000, xxxxxx.xxxxx@xxxxxxxxx.xxx DCI Contact: xxx.xxxxxxx.xxXxxxx Xxxxxx, Vice President Sales and Marketing, +0-000-000-0000; xxxxxxx@xxxxxxxxxxxxx.xxx

Appears in 1 contract

Samples: Confidential Disclosure Agreement (Cornerstone Therapeutics Inc)

Safe Harbor Statement. This Except for the historical and present factual information contained in this press release contains release, the matters discussed in this press release, including statements as to the expected benefits of the merger transaction such as efficiencies, market profile, product offerings and financial strength, and the competitive ability and position of the combined bank, and other statements identified by words such as “will,” “expected,” “plans,” “approximately”, and similar expressions are forward-looking statements within the meaning of Section 27A the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections1995. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of These forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent subject to risks and uncertainties which could that may cause actual results to differ materially from those set forth in the forward-looking statements, including the following: the ability to obtain regulatory approvals and Axxxxxxx shareholder approval of the merger transaction on the proposed terms and schedule; the possibility that costs or difficulties related to the integration of the businesses of Axxxxxxx and The Park National Bank will be greater than expected or that the cost savings and any revenue synergies of the combined banks following the merger transaction may be lower or take longer to realize than expected; disruptions from the merger transaction may make it more difficult to maintain relationships with customers, employees or suppliers; the impact of competition; and other risk factors relating to our industry as a result of various factors including those risks and uncertainties described detailed from time to time in the Risk Factors reports of Park filed with the Securities and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1Exchange Commission (the “SEC”). We urge you to consider those risks and uncertainties in evaluating our forwardForward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which statements speak only as of the date on which they are made. Except as otherwise required by the federal securities laws, we disclaim any and Pxxx undertakes no obligation or undertaking to publicly release any updates or revisions to update any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto events or circumstances after the date on which the forward-looking statement is made, except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Park or any change person acting on Pxxx’s behalf are qualified by these cautionary statements. Further information on other factors which could affect the financial results of Park after the merger transaction are included in events, conditions or circumstances on which any such statement is basedPark’s filings with the SEC. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxThese documents are available free of charge through the website maintained by the SEC at hxxx://xxx.xxx.xxx and/or from Park.

Appears in 1 contract

Samples: Park National Corp /Oh/

Safe Harbor Statement. This press news release contains forward-looking statements within that involve significant risks and uncertainties. Any statement describing the meaning Company’s expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of Section 27A 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company’s capital to support the Company’s operations, the ability of Alexza and Xxxxxx to effectively and profitably commercialize ADASUVE, Alexza’s ability to secure a new U.S. commercial partner for ADASUVE and the terms of any such partnership, estimated product revenues and royalties associated with the sale of ADASUVE, and the Company’s ability to raise additional funds and the potential terms of such potential financings. The Company’s forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza’s business are described in additional detail in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and the Company’s other Periodic and Current Reports filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. CONTACT: Xxxxxx X. Xxxx President and CEO 650.944.7900 (investor / media questions) xxxxxxxx.xxxx@xxxxxx.xxx [*] Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements 131426008 v1 Schedule 3.3 Vendor Agreements [*] [*] Certain confidential information contained in this release that are not based on historical fact are "forward looking statements". While management document, marked by brackets, has based any forward looking statements included in this release on its current expectations, been omitted and filed separately with the information on which such expectations were based may change. Forward-looking statements involve inherent risks Securities and uncertainties which could cause actual results Exchange Commission pursuant to differ materially from those in Rule 24b-2 of the forward-looking statementsSecurities Exchange Act of 1934, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1amended. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xx131426008 v1 Schedule 7.3

Appears in 1 contract

Samples: License and Supply Agreement (Alexza Pharmaceuticals Inc.)

Safe Harbor Statement. This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), regarding product development efforts and other non-historical facts about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects, including statements within regarding expectations about RAYALDEE and the meaning of Section 27A success of the Securities Act collaboration and licensing agreement, whether the parties will obtain regulatory approval for, launch or successfully commercialize RAYALDEE, whether the parties will successfully develop RAYALDEE for the treatment of 1933SHPT in dialysis patients, as amendedthat RAYALDEE will effectively control SHPT in patients with stage 3 or 4 CKD by correcting vitamin D insufficiency, that RAYALDEE will improve the well-being of CKD patients, whether payment milestones and royalty obligations will ever be triggered, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sectionsexpected market for RAYALDEE. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which Many factors could cause our actual activities or results to differ materially from those the activities and results anticipated in the forward-looking statements. These factors include those described in OPKO’s filings with the Securities and Exchange Commission, as a result well as risks inherent in funding, developing and obtaining regulatory approvals of various factors new, commercially-viable and competitive products and treatments, including those the risks that the phase 3 clinical trials for RAYALDEE may not have generated data that would support the approval or marketing of this product for the indications being studied, that others may develop products which are superior to RAYALDEE, and uncertainties described that RAYALDEE may not have advantages or prove to be superior over presently marketed products, including the currently used high monthly doses of prescription vitamin D2, activated vitamin D hormone and over- the-counter vitamin D supplements. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the Risk Factors date the statements were made and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you we do not undertake any obligation to consider those risks and uncertainties in evaluating our update forward-looking statements. We caution readers not to place undue reliance upon any such intend that all forward-looking statements, which speak only as statements be subject to the safe-harbor provisions of the date madePSLRA. Except as otherwise required by the federal securities lawsView source version on xxxxxxxxxxxx.xxx: xxxx://xxx.xxxxxxxxxxxx.xxx/news/home/20160509005380/en/ Xxxxx Xxxxxxxxx Medical Care Renal Pharma Media Relations: Xxxxxxx Xxxx, we disclaim any obligation +00 00 000 00 00 Head of Global Communications & Public Affairs xxxxx@xxxxxxxxxxx.xxx or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in eventsOPKO Health, conditions or circumstances on which any such statement is based. CONTACTInc.: MZ North America Investor relations: Xxxx Xxxxxx Chairman DirectXxxxxx: +0-+0 000-000-0000 Emailor Media - Rooney & Associates: xxxx.xxxxxx@xxxxxxx.xx WebXxxxx Xxxxxx: xxx.xxxxxxx.xx+0 000-000-0000 xxxxxxx@xxxxxxxx.xxx or Xxxxxx Xxxxx: +0 000-000-0000 xxxxxx@xxxxxxxx.xxx or Investors – LHA Xxxx Xxxxx Xxxxxx: +0 000-000-0000 xxxxxxx@xxxx.xxx or Xxxxx Xxxx, +0 000-000-0000 xxxxx@xxxx.xxx

Appears in 1 contract

Samples: d1io3yog0oux5.cloudfront.net

Safe Harbor Statement. This Statements contained in this press release contains regarding matters that are not historical facts are “forward-looking statements statements” within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19331995, as amendedincluding statements associated with the anticipated benefits of our agreement with Merck KGaA, and Section 21E our ability to support the development, regulatory filing and commercialization of the Securities Exchange companion diagnostics. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential,” and Exchange Act of 1934, as amended, that similar expressions are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the identify forward-looking statements, though not all forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various factors including those risks and uncertainties uncertainties, including, without limitation, the risk that we may not realize the expected benefits from our agreement with Merck KGaA, risks associated with the utility of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail in our filings with the Risk Factors Securities and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of Exchange Commission, including, without limitation, our recently filed registration statement Quarterly Report on Form S-110-Q for the quarter ended June 30, 2016. We urge you to consider those risks and uncertainties in evaluating our All forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which statements contained in this press release speak only as of the date on which they were made, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACTContact: MZ North America Xxxx Westwicke Partners Xxxxx Xxxxxx Chairman DirectPhone: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Webxxxxx.xxxxxx@xxxxxxxxx.xxx XX Xxxxxxx President / CEO HTG Molecular Diagnostics Phone: xxx.xxxxxxx.xx000-000-0000 x000 Email: xxxxxxxxx@xxxxxxxxxxxx.xxx Primary Logo

Appears in 1 contract

Samples: investors.htgmolecular.com

Safe Harbor Statement. This press release contains forward-looking statements within that are made pursuant to the meaning safe harbor provisions of Section 27A the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding the status and prospects of our commercialization of FOLOTYN for the treatment of patients with relapsed or refractory PTCL; our Marketing Authorisation Application (MAA) for FOLOTYN in Europe; our future product development and regulatory strategies, including our intent to develop or seek regulatory approval for FOLOTYN in additional indications; our [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended. strategic collaboration with Mundipharma, including the parties intent to co-develop FOLOTYN in additional indications and Mundipharma's potential commercialization of FOLOTYN outside the United States and Canada; and other statements that are intended to be covered by the "safe harbor" created by those sectionsother than statements of historical facts. Forward-looking statementsIn some cases, which are based on certain assumptions and describe our future plans, strategies and expectations, you can generally be identified by the use of identify forward-looking terms statements by terminology such as "believe," "expect," "may," "will," "should" "could," "seekexpects," "intendintends," "planplans," "estimateanticipates," "anticipatebelieves," "estimates," "predicts," "projects," "potential," "continue," and other similar terminology or other comparable the negative of these terms, but their absence does not mean that a particular statement is not forward-looking. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. ForwardSuch forward-looking statements involve inherent are not guarantees of future performance and are subject to risks and uncertainties which could that may cause actual results to differ materially from those anticipated by the forward-looking statements. Important factors that may cause actual results to differ materially include, but are not limited to, the risks and uncertainties associated with the commercialization of FOLOTYN; the ability to expand the approved indications for FOLOTYN; that the design of and data collected from the Company's pivotal PROPEL trial may not be adequate to demonstrate the safety and efficacy of FOLOTYN for the treatment of patients with relapsed or refractory PTCL, or otherwise be sufficient to support EMA approval; and the establishment, implementation and execution of the Company's strategic collaboration with Mundipharma, including the parties future product development and commercialization strategies. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements, as a result of various factors including those risks and uncertainties described statements is contained in the "Risk Factors Factors" section of the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, and in Managementthe Company's Discussion other periodic reports and Analysis of Financial Condition filings with the Securities and Results of Operations sections of our recently filed registration statement on Form S-1Exchange Commission. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers The Company cautions investors not to place undue reliance upon any such on the forward-looking statements, which speak only as of the date madestatements contained in this press release. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any All forward-looking statement contained herein (statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or elsewhere) update these forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions events or circumstances on which any such statement after the date of this presentation, except as required by law. Note: The Allos logo and FOLOTYN name are registered trademarks of Allos Therapeutics, Inc. Sources: Allos Therapeutics, Inc. and Mundipharma International Corporation Limited # # # [ * ] = Certain confidential information contained in this document, marked by brackets, is basedfiled with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. CONTACTEditor's Note: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxThis press release is also available under the Media section of Allos Therapeutics' website at xxx.xxxxx.xxx and at xxx.xxxxxxxxxxx.xx.xx References:

Appears in 1 contract

Samples: License, Development and Commercialization Agreement (Allos Therapeutics Inc)

Safe Harbor Statement. This press release contains includes forward-looking statements within regarding the meaning development, therapeutic potential and safety of Section 27A AZ-004. Any statement describing a product candidate or Alexza’s goals, expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. Alexza’s forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza’s business are described in additional detail in Alexza’s Annual Report on Form 10-K for the year ended December 31, 2008, and Alexza’s other Periodic and Current Reports filed with the Securities and Exchange Commission, including the risks under the headings: “We will need substantial additional capital in the future. If additional capital is not available, we will have to delay, reduce or cease operations.”, “Regulatory authorities may not approve our product candidates even if they meet safety and efficacy endpoints in clinical trials.” and “If we enter into strategic partnerships, we may be required to relinquish important rights to and control over the development of our product candidates or otherwise be subject to terms unfavorable to us.”. Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. CONTACTS: Xxxxxx X. Xxxx President & CEO 650.944.7634 xxxxx@xxxxxx.xxx August X. Xxxxxxx Senior Vice President and CFO 650.944.7788 xxxxxxxx@xxxxxx.xxx 834108 v3/HN [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xx.

Appears in 1 contract

Samples: Collaboration and License Agreement (Alexza Pharmaceuticals Inc.)

Safe Harbor Statement. This press release contains includes forward-looking statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19331995. Any statements, as amendedother than statements of historical fact, including, without limitation, statements regarding Aptevo’s outlook, financial performance or financial condition, our technology and related pipeline, collaboration and partnership opportunities, commercial portfolio, Aptevo’s future growth rates, Aptevo’s ability to timely manufacture its products, and Section 21E of any other statements containing the Securities Exchange words “believes,” “expects,” “anticipates,” “intends,” “plans,” “forecasts,” “estimates,” “will” and Exchange Act of 1934, as amended, that similar expressions are intended to be covered by the "safe harbor" created by those sections. Forwardforward-looking statements, which . These forward-looking statements are based on certain assumptions Aptevo’s current intentions, beliefs and describe our expectations regarding future plans, strategies and expectations, can generally be identified by the use of events. Aptevo cannot guarantee that any forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or other comparable termsunknown risks or uncertainties materialize, actual results could differ materially from Aptevo’s expectations. All statements in this release that are Investors are, therefore, cautioned not based to place undue reliance on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forwardforward-looking statements involve inherent risks and uncertainties which statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, Aptevo does not undertake to update any forward-looking statement to reflect new information, events or circumstances. There are a number of important factors that could cause our actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any indicated by such forward-looking statements, which speak only including possible negative effects on our business operations, assets or financial results as a result of the date madeseparation; a deterioration in our business or prospects; the ability of our contractors and suppliers to supply product and materials; our ability and the ability of our contractors and suppliers to maintain compliance with cGMP and other regulatory obligations; the results of regulatory inspections; adverse developments in our customer-base or markets and our ability to retain patients; adverse developments in the U.S. or global capital markets, credit markets or economies generally; and changes in regulatory, social and political conditions. Except Additional risks and factors that may affect results are set forth in our filings with the Securities and Exchange Commission, including Aptevo’s most recent Annual Report on Form 10-K, as otherwise required by filed on March 15, 2017, and our subsequent reports on Form 10-Q and current reports on Form 8-K. The foregoing sets forth many, but not all, of the federal securities laws, we disclaim any obligation or undertaking factors that could cause actual results to publicly release any updates or revisions to differ from our expectations in any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in eventsstatement. For Further Information: Aptevo Therapeutics Xxxxxx Jurchison, conditions or circumstances on which any such statement is basedSr. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-Director, Investor Relations and Corporate Communications 000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxXxxxxxxxxX@xxxx.xxx

Appears in 1 contract

Samples: Collaboration and Option Agreement (Aptevo Therapeutics Inc.)

Safe Harbor Statement. This press release contains "forward-looking statements statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sectionsprovisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of Such forward-looking terms such as statements include, without limitation, statements regarding the synergies between Spreadtrum and Tsinghua, positioning the Company’s business for continued growth, the increased intellectual property protection for the Company, the unlocking of hidden value, and other anticipated benefits of the merger for shareholders. The Company uses words like "believe," "anticipate," "intend," "estimate," "expect," "may,project" "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward and similar expressions to identify forward-looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forwardalthough not all forward-looking statements contain these words. These statements are forward-looking in nature and involve inherent risks and uncertainties which could that may cause actual market trends and the Company's actual results to differ materially from those expressed or implied in the these forward-looking statements, as statements for a result variety of various factors including those reasons. Potential risks and uncertainties described include, but are not limited to, continuing competitive pressure in the Risk Factors semiconductor industry and the effect of such pressure on prices; unpredictable changes in Managementtechnology and consumer demand for mobile phones; market acceptance of the Company’s smartphone products; transition trend from 2.5G feature phones to smartphones; the state of and any change in the Company's Discussion relationship with its major domestic and Analysis international customers and Chinese government agencies; and changes in political, economic, legal and social conditions in China. For additional discussion of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those these risks and uncertainties and other factors, please consider the information contained in evaluating our forwardthe Company's filings with the U.S. Securities and Exchange Commission (the "SEC") and the annual report on Form 20-looking statements. We caution readers not F filed on April 26, 2013 especially the section under "Risk Factors" and such other documents that the Company may file with the SEC from time to place undue reliance upon time, including on Form 6-K. The Company assumes no obligation to update any such forward-looking statements, which speak apply only as of the date made. Except as otherwise required by the federal securities lawsof this press release, we disclaim any obligation or undertaking and does not intend to publicly release any updates or revisions to update any forward-looking statement contained herein (whether as a result of new information, future events or elsewhere) to reflect any change in our expectations with regard thereto or any change in eventsotherwise except as required by law. SOURCE Spreadtrum Communications, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: Inc. Investor Relations, +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xx0000, ix@xxxxxxxxxx.xxx

Appears in 1 contract

Samples: Spreadtrum Communications Inc

AutoNDA by SimpleDocs

Safe Harbor Statement. This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), regarding product development efforts and other non-historical facts about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects, including statements within regarding expectations about RAYALDEE and the meaning of Section 27A success of the Securities Act collaboration and licensing agreement, whether the parties will obtain regulatory approval for, launch or successfully commercialize RAYALDEE, whether the parties will successfully develop RAYALDEE for the treatment of 1933SHPT in dialysis patients, as amendedthat RAYALDEE will effectively control SHPT in patients with stage 3 or 4 CKD by correcting vitamin D insufficiency, that RAYALDEE will improve the well-being of CKD patients, whether payment milestones and royalty obligations will ever be triggered, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sectionsexpected market for RAYALDEE. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which Many factors could cause our actual activities or results to differ materially from those the activities and results anticipated in the forward-looking statements. These factors include those described in OPKO’s filings with the Securities and Exchange Commission, as a result well as risks inherent in funding, developing and obtaining regulatory approvals of various factors new, commercially-viable and competitive products and treatments, including those the risks that the phase 3 clinical trials for RAYALDEE may not have generated data that would support the approval or marketing of this product for the indications being studied, that others may develop products which are superior to RAYALDEE, and uncertainties described that RAYALDEE may not have advantages or prove to be superior over presently marketed products, including the currently used high monthly doses of prescription vitamin D2, activated vitamin D hormone and over-the-counter vitamin D supplements. In addition, forward-looking statements may also be adversely affected by general market factors, competitive product development, product availability, federal and state regulations and legislation, the regulatory process for new products and indications, manufacturing issues that may arise, patent positions and litigation, among other factors. The forward-looking statements contained in this press release speak only as of the Risk Factors date the statements were made and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you we do not undertake any obligation to consider those risks and uncertainties in evaluating our update forward-looking statements. We caution readers not to place undue reliance upon any such intend that all forward-looking statements, which speak only as statements be subject to the safe-harbor provisions of the date madePSLRA. Except as otherwise required by the federal securities lawsView source version on xxxxxxxxxxxx.xxx: xxxx://xxx.xxxxxxxxxxxx.xxx/news/home/20160509005380/en/ Xxxxx Xxxxxxxxx Medical Care Renal Pharma Media Relations: Xxxxxxx Xxxx, we disclaim any obligation +00 00 000 00 00 Head of Global Communications & Public Affairs xxxxx@xxxxxxxxxxx.xxx or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in eventsOPKO Health, conditions or circumstances on which any such statement is based. CONTACTInc.: MZ North America Investor relations: Xxxx Xxxxxx Chairman DirectXxxxxx: +0-+0 000-000-0000 Emailor Media - Rooney & Associates: xxxx.xxxxxx@xxxxxxx.xx WebXxxxx Xxxxxx: xxx.xxxxxxx.xx+0 000-000-0000 xxxxxxx@xxxxxxxx.xxx or Xxxxxx Xxxxx: +0 000-000-0000 xxxxxx@xxxxxxxx.xxx or Investors – LHA Xxxx Xxxxx Xxxxxx: +0 000-000-0000 xxxxxxx@xxxx.xxx or Xxxxx Xxxx, +0 000-000-0000 xxxxx@xxxx.xxx

Appears in 1 contract

Samples: d1io3yog0oux5.cloudfront.net

Safe Harbor Statement. This Certain matters discussed in this press release contains are “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements within may generally be identified as such because the meaning context of Section 27A such statements will include words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or words of the Securities Act of 1933similar import. Similarly, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, statements that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of objectives or goals are also forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable termsstatements. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. ForwardSuch forward-looking statements involve inherent are subject to certain risks and uncertainties which that could cause actual results to differ materially from those expected. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this press release and we undertake no obligation to publicly update any forward-looking statements, whether as a result of various new information, future events or otherwise. More detailed information about factors including those risks that may affect our performance may be found in our filings with the Securities and uncertainties described Exchange Commission, which are available at hxxx://xxx.xxx.xxx or at hxxx://xxxxxxxx.xxxxxxx.xxx/ in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections Investor Relations section of our recently filed registration statement on Form S-1Website. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statementsOrion Contact Sxxxx Xxxxxx, which speak only as of the date made. Except as otherwise required by the federal securities lawsDirector Marketing & Communications Orion Energy Systems, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein Inc. sxxxxxx@xxxx.xxx (or elsewhere000) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 EmailInvestor Relations Contacts Pxx Xxxxxx, CFO Wxxxxxx Xxxxx; Dxxxx Xxxxxxx Orion Energy Systems, Inc. Catalyst IR pxxxxxx@xxxx.xxx (000) 000-0000 or oxxx@xxxxxxxx-xx.xxx Engage with Us Twitter: xxxx.xxxxxx@xxxxxxx.xx Web@OrionLighting and @OrionLightingIR StockTwits: xxx.xxxxxxx.xx@Orion_LED_IR

Appears in 1 contract

Samples: Cooperation Agreement (Orion Energy Systems, Inc.)

Safe Harbor Statement. This Statements contained in this press release contains regarding matters that are not historical facts are “forward-looking statements statements” within the meaning of Section 27A of the Private Securities Litigation Reform Act of 19331995, as amendedincluding statements associated with the anticipated benefits of our agreement with Merck KGaA, and Section 21E our ability to support the development, regulatory filing and commercialization of the Securities Exchange companion diagnostics. Words such as “believes,” “anticipates,” “plans,” “expects,” “intends,” “will,” “goal,” “potential,” and Exchange Act of 1934, as amended, that similar expressions are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the identify forward-looking statements, though not all forward-looking statements necessarily contain these identifying words. These forward-looking statements are based upon management’s current expectations, are subject to known and unknown risks, and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various factors including those risks and uncertainties uncertainties, including, without limitation, the risk that we may not realize the expected benefits from our agreement with Merck KGaA, risks associated with the utility of our automation systems, proprietary profiling panels and solutions, and our ability to successfully manufacture and supply our products. These and other factors are described in greater detail in our filings with the Risk Factors Securities and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of Exchange Commission, including, without limitation, our recently filed registration statement Quarterly Report on Form S-110-Q for the quarter ended June 30, 2016. We urge you to consider those risks and uncertainties in evaluating our All forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which statements contained in this press release speak only as of the date on which they were made, and we undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forwardContact: Westwicke Partners Xxxxx Xxxxxx Phone: 000-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT000-0000# Email: MZ North America Xxxx Xxxxxx Chairman Directxxxxx.xxxxxx@xxxxxxxxx.xxx XX Xxxxxxx# President / CEO# HTG Molecular Diagnostics Phone: +0-000-000-0000 x000# Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxxxxxxxxxx@xxxxxxxxxxxx.xxx Primary Logo

Appears in 1 contract

Samples: htgmolecular.gcs-web.com

Safe Harbor Statement. This press release report contains statements that are not historical facts but rather forward-looking statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections1995. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of Such forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" statements include those that address activities, events or other comparable termsdevelopments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including without limitation, management’s examination of historical operating trends and data, as well as estimates of future sales, operating margin, cash flow, effective tax rate or other future operating performance or financial results, are based upon our current expectations, various assumptions and data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a result reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. Because these forward- looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward- looking statements for a variety of reasons, including without limitation, changes in global light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier, changes in general industry and market conditions, changes in and the successful execution of our capacity alignment, restructuring and cost reduction initiatives discussed herein and the market reaction thereto; loss of business from increased competition; higher raw material, fuel and energy costs; changes in consumer and customer preferences for end products; customer losses; changes in regulatory conditions; customer bankruptcies or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various factors jurisdictions in which we operate; component shortages; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing negotiations with customers, our ability to be awarded new business; product liability, warranty and recall claims and other litigation and customer reactions thereto; higher expenses for our pension and other postretirement benefits; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims; negative impacts of antitrust investigations or other governmental investigations and associated litigation (including those securities litigation) relating to the conduct of our business; tax assessments by governmental authorities and changes in our effective tax rate; dependence on key personnel; legislative or regulatory changes limiting our business; political conditions; dependence on and relationships with customers and suppliers; and other risks and uncertainties described in identified under the headings “Risk Factors Factors” and in Management's ’s Discussion and Analysis of Financial Condition and Results of Operations sections of Operations” in our recently filed registration statement Annual Reports and Quarterly Reports on Form S-1Forms 10-K and 10-Q and any amendments thereto. We urge you The Company undertakes no obligation to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation update publicly or undertaking to publicly release any updates or revisions to revise any forward-looking statement statements in light of new information or future events. For any forward-looking statements contained herein (or elsewhere) to reflect any change in our expectations with regard thereto this or any change other document, we claim the protection of the safe harbor for forward-looking statements contained in eventsthe Private Securities Litigation Reform Act of 1995, conditions or circumstances on which and we assume no obligation to update any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxstatement.

Appears in 1 contract

Samples: www.autoliv.com

Safe Harbor Statement. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, including statements about the growth and profitability of the Company. Any statements in this press release that are intended not statements of historical fact may be considered to be covered by the "safe harbor" created by those sections. Forwardforward-looking statements. Written words, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "shouldexpect," "couldbelieve," "anticipate," "estimate," "intends," "goal," "objective," "seek," "intendattempt," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward variations of these or similar words, identify forward-looking statements". While management has based any forward looking statements included in this release on its current expectationsBy their nature, the information on which such expectations were based may change. Forwardforward-looking statements and forecasts involve inherent risks and uncertainties which because they relate to events and depend on circumstances that will occur in the near future. There are a number of factors that could cause actual results and developments to differ materially, including, but not limited to our ability to: successfully implement our strategy to stabilize our subscriber base and grow; avoid significant subscriber declines; attract and retain members; convert members into paying subscribers and retain our paying subscribers; retain and enhance the new marketing team; develop or acquire new product offerings and successfully implement and expand those offerings; keep pace with rapid technological changes, including making the technology stack more nimble; drive use of newly-updated mobile applications; maintain the strength of our existing brands and maintain and enhance those brands; continue to depend upon the telecommunications infrastructure and our networking hardware and software infrastructure; estimate on-going general and administrative costs, and obtain financing on acceptable terms. Additional factors that could cause actual results to differ materially from those are discussed under the heading "Risk Factors" and in other sections of the Company's filings with the Securities and Exchange Commission ("SEC"), and in the Company's other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements, as a result of various factors including those risks and uncertainties described statements in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only this press release are made as of the date made. Except hereof, based on information available to the Company as otherwise required by of the federal securities lawsdate hereof, we disclaim any and the Company assumes no obligation or undertaking to publicly release any updates or revisions to update any forward-looking statement contained herein (or elsewhere) to reflect any change provide similar metrics in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxfuture periods.

Appears in 1 contract

Samples: Nomination and Standstill Agreement (Spark Networks Inc)

Safe Harbor Statement. This press news release contains forward-looking statements statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "willshould," "should" "could," "seek," "intend," "plan," "goal," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on other than statements of historical fact are "forward looking statements". While management has based any forward looking statements facts included in this news release on its current expectationsregarding our strategies, the information on which such expectations were based may changeprospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Forward-looking statements involve are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and uncertainties changes in circumstances that are difficult to predict and many of which could cause are outside of our control. Our actual results to and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, as a result you should not rely on any of various these forward-looking statements. Important factors including that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; the acceptance of our products and services by customers; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other security and telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, strategic alliance agreements, licensing and supplier arrangements; our ability to comply with applicable regulations; and the other risks and uncertainties described in our prior filings with the Risk Factors Securities and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1Exchange Commission. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any undertake no obligation or undertaking to publicly release any updates or revisions to update any forward-looking statement contained herein (statement, whether written or elsewhere) oral, that may be made from time to reflect any change in our expectations with regard thereto time, whether as a result of new information, future developments or any change in eventsotherwise. Media contact: DarkPulse Solutions, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxInc. Xxxx@XxxxXxxxx.xxx

Appears in 1 contract

Samples: Signs Agreement (DarkPulse, Inc.)

Safe Harbor Statement. This press release contains certain forward-looking statements within that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the meaning of Section 27A operation of the Securities Act collaboration with Amgen, the efficacy, safety and intended utilization of 1933our product candidates, including the BiTE antibodies that are the subject of the agreement with Amgen, the mode of action of BiTE antibodies, the conduct, timing and results of future clinical trials, expectations of the future expansion of our product pipeline and collaborations, the initiation of a second BiTE program under the collaboration with Amgen and the future payment of upfront, milestone and royalty payments by Amgen. You are urged to consider statements that include the words "ongoing," "may," “eligible,” "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that our product candidates do not demonstrate safety and/or efficacy in pre-clinical studies or clinical trials, delays in development and testing, including the risk that Amgen will not obtain approval to market our product candidates and the risks associated with reliance on collaboration partners such as Amgen and outside financing to meet capital requirements. These factors and others are more fully discussed in Micromet's Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2010, and Section 21E Micromet’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2011, filed with the SEC on May 10, 2011 as well as other filings by the Company with the SEC. *** Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange and Exchange Act of 1934, as amended. ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4), that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statementsand 240.24b-2 Contact: Xxxxxxxx Xxxxxx Director, which are based on certain assumptions and describe our future plansCorporate Communications Micromet, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should" "could," "seek," "intend," "plan," "estimate," "anticipate" or other comparable terms. All statements in this release that are not based on historical fact are "forward looking statements". While management has based any forward looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our recently filed registration statement on Form S-1. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. CONTACT: MZ North America Xxxx Xxxxxx Chairman Direct: +0-Inc. 000-000-0000 Email: xxxx.xxxxxx@xxxxxxx.xx Web: xxx.xxxxxxx.xxxxxxxxxx.xxxxxx@xxxxxxxx.xxx *** Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. ***Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4), and 240.24b-2 Exhibit H Dispute Resolution Procedures for Certain Matters

Appears in 1 contract

Samples: Collaboration and License Agreement (Micromet, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.